{ "company": "Laboratory Corporation of America", "ticker": "LH", "period": { "from": "2026-02-26", "to": "2026-03-28", "days": 30 }, "sentiment_breakdown": { "positive": 27, "negative": 12, "neutral": 37 }, "synthesis": { "executive_summary": "**Executive Summary: Laboratory Corporation of America (LH) Sentiment Analysis**\n\nDuring the period from February 26 to March 28, 2026, sentiment analysis for Laboratory Corporation of America (LH) revealed a predominantly neutral outlook, accounting for 48.7% of the 76 monitored items. Positive sentiment comprised 35.5%, significantly outweighing negative sentiment at 15.8%, indicating a cautiously optimistic environment. Key positive drivers for LH included the company's proactive financial guidance, targeting 5.4% midpoint revenue growth and 9% EPS growth for 2026, driven by strategic advancements in specialty testing and AI initiatives. This was reinforced by a 'Moderate Buy' analyst consensus and a recent EPS beat.\n\nThe most significant positive event directly impacting LH was the detailed outline of its 2026 financial targets, emphasizing growth through specialty and AI initiatives, which garnered positive market reception. Conversely, a notable negative event, as classified by sentiment analysis, was the expanded collaboration between Labcorp and Illumina for precision oncology testing. Despite the initiative's apparent benefits, the sentiment model flagged this item as negative, suggesting potential underlying concerns or nuanced market interpretation. Broader negative sentiment also arose from industry pressures affecting competitors and related sectors, including analyst downgrades for peers and softening demand in the lab equipment market, signaling potential headwinds for the diagnostics industry.", "key_findings": [ "โœ“ I was recommended this sub for my boy Oreo ๐Ÿ’–๐Ÿฐ", "โœ“ BREAKING: Google Just Reached True Quantum Supremacy By Processing Data 13,000 Times Faster Than The World's Best Supercomputer ๐Ÿค–๐Ÿ”ฅ", "โœ“ Costco Announces Partnership with Sesame and IVI RMA (World's Largest Assisted Reproduction Group) to Expand Fertility Care, Cut Medication Costs by 80% for Costco Members", "โœ— Labcorpโ€“Illumina cancer pact targets wider access to genomic tests", "โœ— Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach", "โœ— OPKO Health Inc stock faces analyst cuts as earnings outlook darkens amid biotech pressures" ], "overall_sentiment": "positive" }, "top_positive": [ { "title": "I was recommended this sub for my boy Oreo ๐Ÿ’–๐Ÿฐ", "date": "2026-03-19", "source": "reddit", "score": 0.802 }, { "title": "BREAKING: Google Just Reached True Quantum Supremacy By Processing Data 13,000 Times Faster Than The World's Best Supercomputer ๐Ÿค–๐Ÿ”ฅ", "date": "2026-03-15", "source": "reddit", "score": 0.735 }, { "title": "Costco Announces Partnership with Sesame and IVI RMA (World's Largest Assisted Reproduction Group) to Expand Fertility Care, Cut Medication Costs by 80% for Costco Members", "date": "2026-03-14", "source": "reddit", "score": 0.727 }, { "title": "Earnest Partners LLC Sells 7,799 Shares of Labcorp Holdings Inc. $LH", "date": "2026-03-15", "source": "alpha_vantage", "score": 0.67 }, { "title": "Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives", "date": "2026-03-18", "source": "alpha_vantage", "score": 0.582 }, { "title": "Labcorp Holdings Inc. $LH Shares Purchased by Swiss Life Asset Management Ltd", "date": "2026-03-21", "source": "alpha_vantage", "score": 0.572 }, { "title": "Labcorp Holdings Inc. $LH Shares Bought by Gotham Asset Management LLC", "date": "2026-03-17", "source": "alpha_vantage", "score": 0.572 }, { "title": "Integral Health Asset Management LLC Sells 65,000 Shares of Quest Diagnostics Incorporated $DGX", "date": "2026-03-14", "source": "alpha_vantage", "score": 0.572 }, { "title": "Canvas Exam Help Online | Pay someone to take my Canvas exam | Pay Someone to do my Canvas Class | Do my Canvas Homework | Do my Canvas Assignment | Take my Canvas QUIZ | Canvas Test Taker Hire | College Math Chemistry Statistics Accounting Calculus Business Physics Tutoring Exam Help Hiraedu Reddit", "date": "2026-03-01", "source": "reddit", "score": 0.557 }, { "title": "Illumina and Labcorp Expand Precision Oncology Testing Partnership", "date": "2026-03-20", "source": "alpha_vantage", "score": 0.518 } ], "top_negative": [ { "title": "Labcorpโ€“Illumina cancer pact targets wider access to genomic tests", "date": "2026-03-18", "source": "alpha_vantage", "score": -0.66 }, { "title": "Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach", "date": "2026-03-14", "source": "alpha_vantage", "score": -0.599 }, { "title": "OPKO Health Inc stock faces analyst cuts as earnings outlook darkens amid biotech pressures", "date": "2026-03-23", "source": "alpha_vantage", "score": -0.542 }, { "title": "Kewaunee Scientific stock (ISIN: US4925721028) faces margin pressure as lab-furniture demand softens", "date": "2026-03-16", "source": "alpha_vantage", "score": -0.402 }, { "title": "VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation", "date": "2026-03-17", "source": "alpha_vantage", "score": -0.34 }, { "title": "OPKO Health Inc stock faces pressure amid insider buying and Labcorp deal aftermath", "date": "2026-03-24", "source": "alpha_vantage", "score": -0.296 }, { "title": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors", "date": "2026-03-18", "source": "alpha_vantage", "score": -0.2 }, { "title": "Confirmed Upcoming Layoffs: February 2026", "date": "2026-02-26", "source": "reddit", "score": -0.2 }, { "title": "Banco Bilbao Vizcaya Argentaria S.A. Lowers Stock Holdings in Labcorp Holdings Inc. $LH", "date": "2026-03-17", "source": "alpha_vantage", "score": -0.128 }, { "title": "California Public Employees Retirement System Lowers Holdings in Labcorp Holdings Inc. $LH", "date": "2026-03-17", "source": "alpha_vantage", "score": -0.128 } ], "raw_data": { "total_items": 76, "items": [ { "source": "sec", "filing_type": "8-K", "title": "8-K - Current report", "date": "2026-03-20", "url": "https://www.sec.gov/Archives/edgar/data/920148/000119312526117879/0001193125-26-117879-index.htm", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. stock outperforms competitors despite losses on the day", "url": "https://www.marketwatch.com/data-news/labcorp-holdings-inc-stock-outperforms-competitors-despite-losses-on-the-day-b2fb8e95-b0569bf8b796?gaa_at=eafs&gaa_n=AWEtsqeFDW9_p2nswIRAZ5V7QYehFLF4F-IS_rYr_03p--_Iw3sTW-zTsm86&gaa_ts=69c788d7&gaa_sig=ex6b3-sLI8rw8NweaoWnGF0JHsyQxDrtv6JtDqcvc_HcDyDWyTyE-fwBbi3auEk8-0p4Ftgi_VItqJ8BQHEa3A%3D%3D", "date": "2026-03-27", "summary": "Labcorp Holdings Inc. (LH) shares decreased by 1.56% to $264.20, underperforming the broader market downturn where the S&P 500 Index and Dow Jones Industrial Average also fell significantly. Despite the daily loss, Labcorp Holdings Inc. closed 10.05% below its 52-week high, indicating a relative outperformance compared to the harsher market correction. The article highlights the company's stock performance in the context of a challenging trading session.", "sentiment_score": 0.045741, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.309, "confidence": 0.31 } }, { "source": "alpha_vantage", "title": "Onconetix Completes Reverse Stock Split to Maintain Listing", "url": "https://www.tipranks.com/news/company-announcements/onconetix-completes-reverse-stock-split-to-maintain-listing", "date": "2026-03-27", "summary": "Onconetix (ONCO) completed a 1-for-5 reverse stock split on March 25, 2026, reducing outstanding shares from 3.6 million to 0.7 million. This action aims to help the biotechnology company, which specializes in men's health and oncology diagnostics, maintain compliance with Nasdaq's $1.00 minimum bid price requirement. Despite the move, TipRanksโ€™ AI Analyst, Spark, rates ONCO as an Underperform due to substantial financial difficulties and a bearish technical outlook.", "sentiment_score": 0.129785, "sentiment_label": "Neutral", "relevance_score": 0.638235, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Stock: Business Model, Market Position and Investor Considerations for US50540R4092", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/labcorp-holdings-stock-business-model-market-position-and-investor/69004784", "date": "2026-03-27", "summary": "Labcorp Holdings Inc. (NYSE: LH) is a leading provider of clinical laboratory services, with its stock trading around $266 on the NYSE. The company's business model is divided into Diagnostics and Biopharma Services, benefiting from a vast network and strategic acquisitions in genomics and at-home testing. Labcorp's strong market position, solid financial health, and strategic growth initiatives position it as a defensive play for North American investors seeking exposure to the resilient health", "sentiment_score": 0.428436, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "A Look At Labcorp Holdings (LH) Valuation After Illumina Alliance Puts Precision Oncology In Focus", "url": "https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-illumina-allia", "date": "2026-03-27", "summary": "Labcorp Holdings (LH) is under scrutiny following an expanded collaboration with Illumina, focusing on precision oncology. The article explores Labcorp's valuation, noting it's considered 12.8% undervalued with a fair value of $307.71, despite its P/E ratio of 25.2x being above the US Healthcare industry average. It advises investors to consider both the growth potential from innovative diagnostics and operational efficiencies, as well as risks from regulatory changes and Medicare pricing.", "sentiment_score": 0.317998, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.967726, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Pensionfund Sabic Takes $1.11 Million Position in Quest Diagnostics Incorporated $DGX", "url": "https://www.marketbeat.com/instant-alerts/filing-pensionfund-sabic-takes-111-million-position-in-quest-diagnostics-incorporated-dgx-2026-03-26/", "date": "2026-03-26", "summary": "Pensionfund Sabic initiated a new position in Quest Diagnostics (NYSE:DGX) in Q4, acquiring 6,400 shares valued at approximately $1.11 million. This move comes as Quest Diagnostics exceeded Q4 earnings expectations, announced a $1.0 billion share repurchase program, and raised its quarterly dividend. Analysts currently rate the stock with a consensus \"Moderate Buy\" and an average price target of $210.29.", "sentiment_score": 0.110687, "sentiment_label": "Neutral", "relevance_score": 0.612584, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Assessing Illumina (ILMN) Valuation After New Labcorp And Preventive Genomics Alliances", "url": "https://www.sahmcapital.com/news/content/assessing-illumina-ilmn-valuation-after-new-labcorp-and-preventive-genomics-alliances-2026-03-24", "date": "2026-03-25", "summary": "Illumina has recently expanded its collaborations with Labcorp and entered a new consortium, driving its stock momentum, with a 5.2% 30-day return. Despite recent gains, the 1-year return is strong, contrasting with weaker 3 and 5-year returns, indicating a recent upturn. The company is currently valued at a discount to analyst targets and an intrinsic value estimate of $136.05, raising questions about whether current pricing fully accounts for future growth from these new alliances.", "sentiment_score": 0.245597, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.703419, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Onconetix Highlights Realbotixโ€™s Role in Ericssonโ€™s World-First 6G Trial Demonstration", "url": "https://www.globenewswire.com/news-release/2026/03/25/3262465/0/en/Onconetix-Highlights-Realbotix-s-Role-in-Ericsson-s-World-First-6G-Trial-Demonstration.html", "date": "2026-03-25", "summary": "Onconetix Inc. is drawing attention to Realbotix Corp.'s participation in Ericsson's pre-standard 6G over-the-air trial, where a Realbotix humanoid robot served as a live connected endpoint. Onconetix is in the process of acquiring Realbotix LLC, the subsidiary of Realbotix Corp., in an all-stock transaction expected to close in the second half of 2026. The demonstration showcased how future wireless networks and AI-driven robotics can integrate, highlighting Realbotix's flexible AI-agnostic arc", "sentiment_score": 0.141519, "sentiment_label": "Neutral", "relevance_score": 0.634849, "sentiment": { "label": "positive", "score": 0.103, "confidence": 0.1 } }, { "source": "alpha_vantage", "title": "U.S. Compound Management Market Is Going to Boom | Thermo Fisher", "url": "https://www.openpr.com/news/4439576/u-s-compound-management-market-is-going-to-boom-thermo-fisher", "date": "2026-03-25", "summary": "Coherent Market Insights has published a report on the \"U.S. Compound Management Market: Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2026-2033\". The report provides an in-depth analysis of market performance, competition, regional distribution, and growth potential, making it a valuable tool for entrepreneurs, investors, and business strategists. It also includes key market players, segmentation by end-user, research methodology, and strategic points of analysis.", "sentiment_score": 0.714479, "sentiment_label": "Bullish", "relevance_score": 0.622899, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Onconetix, Inc. Announces 1-for-5 Reverse Stock Split", "url": "https://www.sahmcapital.com/news/content/onconetix-inc-announces-1-for-5-reverse-stock-split-2026-03-23", "date": "2026-03-24", "summary": "Onconetix, Inc. announced a 1-for-5 reverse stock split of its common stock, effective March 25, 2026, to maintain compliance with Nasdaq's minimum bid price requirement. This split, approved by stockholders earlier, will reduce the outstanding shares from approximately 3.6 million to 0.7 million, with fractional shares being cashed out. The company's stock will continue to trade under the symbol \"ONCO\" on The Nasdaq Capital Market.", "sentiment_score": 0.140378, "sentiment_label": "Neutral", "relevance_score": 0.658654, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Illumina Inc. stock faces headwinds amid Grail divestiture scrutiny and biotech sector slowdown", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/illumina-inc-stock-faces-headwinds-amid-grail-divestiture-scrutiny-and/68977501", "date": "2026-03-24", "summary": "Illumina Inc. is facing significant challenges, including regulatory scrutiny over its past Grail acquisition and a slowdown in the biotech sector. Despite a robust balance sheet and ongoing R&D investments, the company's stock is under pressure from softening demand in genomic sequencing, increased competition, and lingering legal ramifications from the Grail divestiture. Investors are closely watching if Illumina can successfully navigate these headwinds and recover its growth trajectory.", "sentiment_score": 0.101032, "sentiment_label": "Neutral", "relevance_score": 0.594037, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "ICON, Advarra Partner on Connected Site Network Model", "url": "https://www.contractpharma.com/breaking-news/icon-advarra-partner-on-connected-site-network-model/", "date": "2026-03-24", "summary": "ICON plc and Advarra have formed a strategic partnership to develop a \"research-ready\" connected site network model for clinical trials. This collaboration aims to integrate ICONโ€™s global clinical trial services with Advarraโ€™s site systems, including CTMSs, eISF, and eSource, to streamline operations. The goal is to reduce administrative burdens, accelerate study startup, and improve overall clinical trial participation and efficiency by leveraging Advarra's operational intelligence platform.", "sentiment_score": 0.32889, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.709344, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "OPKO Health Inc stock faces pressure amid insider buying and Labcorp deal aftermath", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/opko-health-inc-stock-faces-pressure-amid-insider-buying-and-labcorp-deal/68975045", "date": "2026-03-24", "summary": "OPKO Health Inc. shares are experiencing pressure despite CEO Phillip Frost's recent share purchases and the positive impact of its BioReference oncology diagnostics business sale to Labcorp. While the divestiture boosted Q3 2025 profits, the company still faces ongoing losses and a significant foreign tax assessment. US investors are monitoring OPKO's pipeline progress in therapeutics and its strengthened cash position for potential turnaround, with insider buying signaling confidence and techn", "sentiment_score": 0.201775, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.741172, "sentiment": { "label": "negative", "score": -0.296, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Assessing Illumina (ILMN) Valuation After New Labcorp And Preventive Genomics Alliances", "url": "https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ilmn/illumina/news/assessing-illumina-ilmn-valuation-after-new-labcorp-and-prev", "date": "2026-03-24", "summary": "Illumina has recently expanded its collaboration with Labcorp and formed a new consortium, which is expected to boost its position in cancer care and preventive genomics. Despite a recent positive short-term stock performance, the company's valuation narrative suggests it is 9% undervalued at $136.05, driven by strong growth in clinical applications and increasing adoption of next-generation sequencing. Investors should evaluate these factors, remaining mindful of potential risks like China and ", "sentiment_score": 0.02166, "sentiment_label": "Neutral", "relevance_score": 0.307968, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "OPKO Health Inc stock faces analyst cuts as earnings outlook darkens amid biotech pressures", "url": "https://www.ad-hoc-news.de/boerse/ueberblick/opko-health-inc-stock-faces-analyst-cuts-as-earnings-outlook-darkens-amid/68969867", "date": "2026-03-23", "summary": "OPKO Health Inc (NASDAQ:OPK) is facing significant analyst downgrades, with Zacks Research slashing Q3 2026 EPS estimates to -0.07, highlighting broader profitability challenges. The biotech firm is grappling with revenue pressures in its diagnostics business and slow pharmaceutical ramp-up, leading to caution from analysts like Barrington Research, which cut its price target to $1.50. Despite strategic asset sales and insider confidence, the stock's future hinges on stabilizing earnings and pip", "sentiment_score": 0.119281, "sentiment_label": "Neutral", "relevance_score": 0.744602, "sentiment": { "label": "negative", "score": -0.542, "confidence": 0.54 } }, { "source": "alpha_vantage", "title": "Labcorp closes purchase of New York pathology reference lab assets", "url": "https://finance.yahoo.com/sectors/healthcare/articles/labcorp-closes-purchase-york-pathology-100000145.html", "date": "2026-03-23", "summary": "Labcorp has completed its acquisition of assets from Crouse Health's pathology reference laboratory, Laboratory Alliance of Central New York, and will also manage operations at Crouse's inpatient lab. This follows Labcorp's earlier acquisition of assets from Empire City Laboratories. The deals aim to enhance access to diagnostic services in central New York, although they have also resulted in facility closures and layoffs impacting over 200 workers.", "sentiment_score": 0.412607, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "Nordea Investment Management AB Has $243.04 Million Stock Holdings in Labcorp Holdings Inc. $LH", "url": "https://www.marketbeat.com/instant-alerts/filing-nordea-investment-management-ab-has-24304-million-stock-holdings-in-labcorp-holdings-inc-lh-2026-03-23/", "date": "2026-03-23", "summary": "Nordea Investment Management AB reduced its stake in Labcorp Holdings Inc. by 36.4% in Q4, but still holds 1.17% of the company, valued at $243.04 million. Despite insider selling activity, institutional investors maintain a strong presence, owning 95.94% of the stock. Labcorp exceeded quarterly EPS estimates and provided positive FY2026 guidance, leading to a \"Moderate Buy\" consensus among analysts with an average price target of $304.82.", "sentiment_score": 0.411778, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Guardant Health (GH) Valuation Check As New Manulife Partnership Expands Shield Testing In Asia", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-valuation-check-as-new-manulife-partnersh", "date": "2026-03-23", "summary": "Guardant Health (GH) is under scrutiny after announcing a partnership with Manulife to expand its Shield multi-cancer detection blood test in Asia, starting April 2026. Despite recent share price volatility, the company has shown strong long-term momentum with an 84.77% one-year return, yet some models suggest it's significantly undervalued. The article debates whether the market has already factored in future growth, highlighting potential valuation risks from a high P/S ratio compared to the i", "sentiment_score": 0.041842, "sentiment_label": "Neutral", "relevance_score": 0.627984, "sentiment": { "label": "positive", "score": 0.303, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Labcorp expands PathAI partnership to deploy digital pathology platform nationwide", "url": "http://www.msn.com/en-us/health/other/labcorp-expands-pathai-partnership-to-deploy-digital-pathology-platform-nationwide/ar-AA1WTuBT?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "date": "2026-03-21", "summary": "Labcorp has expanded its partnership with artificial intelligence company PathAI to introduce a digital pathology platform across its U.S. network. This collaboration aims to enhance diagnostic capabilities and improve patient care by integrating AI-powered technology into pathology workflows. The deployment builds on a previous agreement, signaling a significant move towards digitizing laboratory diagnostics.", "sentiment_score": 0.340345, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.303, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. $LH Shares Purchased by Swiss Life Asset Management Ltd", "url": "https://www.marketbeat.com/instant-alerts/filing-labcorp-holdings-inc-lh-shares-purchased-by-swiss-life-asset-management-ltd-2026-03-21/", "date": "2026-03-21", "summary": "Swiss Life Asset Management Ltd significantly increased its stake in Labcorp Holdings Inc. by 121.0% in Q3, now holding shares valued at over $10.63 million. Despite insider selling, analysts maintain a \"Moderate Buy\" rating with an average price target of $304.82 for Labcorp, which recently surpassed EPS estimates and provided positive FY2026 guidance. The company also announced a quarterly dividend.", "sentiment_score": 0.47794, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "alpha_vantage", "title": "Form 8K Labcorp Holdings Inc For: 20 March", "url": "https://m.investing.com/news/filings/form-8k-labcorp-holdings-inc-for-20-march-93CH-4573756?ampMode=1", "date": "2026-03-20", "summary": "This article announces the filing of a Form 8K by Labcorp Holdings Inc. for March 20th. It is a brief report from Investing.com, providing basic information about the regulatory filing. The article also includes standard disclaimers about the risks associated with trading financial instruments and cryptocurrencies.", "sentiment_score": 0.033751, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Secures New $750 Million Term Loan", "url": "https://www.tipranks.com/news/company-announcements/labcorp-holdings-secures-new-750-million-term-loan", "date": "2026-03-20", "summary": "Labcorp Holdings (LH) has secured a new $750 million senior unsecured term loan, maturing on March 20, 2028. This loan, fully funded at closing, bears a floating interest rate and includes customary covenants, such as a maximum consolidated leverage ratio of 4.0x. An analyst has rated LH stock a Hold with a $300 price target, while TipRanks' AI Analyst, Spark, rates it as an Outperform due to improving operational outlook and technical momentum.", "sentiment_score": 0.422895, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Labcorp Secures $750 Million Unsecured Term Loan Maturing 2028 With Wells Fargo", "url": "https://www.tradingview.com/news/tradingview:819b4318f5046:0-labcorp-secures-750-million-unsecured-term-loan-maturing-2028-with-wells-fargo/", "date": "2026-03-20", "summary": "Labcorp has secured a new $750 million senior unsecured term loan credit agreement, fully funded on March 20, 2026, and maturing on March 20, 2028. The loan, which bears interest at a SOFR-based rate plus 0.700% or a base rate plus 0%, is expected to enhance the company's liquidity and financial flexibility. Wells Fargo Bank is the administrative agent for the facility.", "sentiment_score": 0.376453, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.178, "confidence": 0.18 } }, { "source": "alpha_vantage", "title": "Labcorp (NYSE: LH) secures $750M unsecured term loan due 2028", "url": "https://www.stocktitan.net/sec-filings/LH/8-k-labcorp-holdings-inc-reports-material-event-a2c614c3fbf3.html", "date": "2026-03-20", "summary": "Labcorp Holdings Inc. (NYSE: LH) has secured a new $750 million senior unsecured term loan facility, maturing on March 20, 2028. The loan, fully funded at closing, features a floating interest rate tied to SOFR or a base rate, plus a margin. The agreement includes customary covenants limiting additional debt and liens, and requires Labcorp to maintain a consolidated leverage ratio not exceeding 4.0 to 1.0, with a temporary increase to 4.5 to 1.0 allowed for material acquisitions under a \"Leverag", "sentiment_score": 0.055132, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.077, "confidence": 0.08 } }, { "source": "alpha_vantage", "title": "Illumina and Labcorp Expand Precision Oncology Testing Partnership", "url": "https://oncodaily.com/techology/illumina471908", "date": "2026-03-20", "summary": "Illumina and Labcorp have expanded their collaboration to advance precision oncology through next-generation sequencing (NGS) by developing distributed IVD test offerings and co-commercializing liquid and tissue biopsy assays. This partnership aims to improve access to advanced biomarker testing in community health systems and underserved regions by enabling local testing and supporting targeted therapy development. The initiative builds on strong scientific collaboration and clinical evidence, ", "sentiment_score": 0.322987, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.911434, "sentiment": { "label": "positive", "score": 0.518, "confidence": 0.52 } }, { "source": "alpha_vantage", "title": "A Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance", "url": "https://simplywall.st/stocks/us/healthcare/nyse-lh/labcorp-holdings/news/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illum", "date": "2026-03-19", "summary": "Labcorp Holdings (LH) has expanded its collaboration with Illumina to enhance access to next-generation sequencing for precision oncology tests. Despite a 1-year total shareholder return of 13.21%, the stock trades at US$264.09, which Simply Wall St identifies as undervalued by approximately 14.2% with a fair value of $307.71, based on anticipated revenue growth from new tests and improved margins through technology. However, potential risks like tariffs and increased competition could affect th", "sentiment_score": 0.025593, "sentiment_label": "Neutral", "relevance_score": 0.325945, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Why has Labcorp (LH) dropped 4.6% following its most recent earnings announcement?", "url": "https://www.bitget.com/news/detail/12560605281930", "date": "2026-03-19", "summary": "Labcorp (LH) stock has declined by 4.6% over the past month despite reporting strong Q4 2025 adjusted earnings per share that surpassed analyst expectations and increased significantly year-over-year. While revenue also grew, it slightly missed analyst projections. The article notes that analyst estimates have seen a downward trend, leading the company to hold a Zacks Rank #3 (Hold).", "sentiment_score": -0.191904, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Why has Labcorp (LH) dropped 4.6% following its most recent earnings announcement?", "url": "https://www.bitget.com/amp/news/detail/12560605281930", "date": "2026-03-19", "summary": "Labcorp (LH) stock dropped 4.6% over the past month despite reporting strong Q4 2025 adjusted earnings per share and revenue growth. While the company surpassed analyst expectations on adjusted EPS, it slightly missed revenue projections, and analyst estimates for its future performance have moved lower. Labcorp projects continued revenue growth and adjusted EPS for 2026, holding a Zacks Rank #3 (Hold).", "sentiment_score": -0.211114, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "ILMN Stock Gains Following Expanded Collaboration With Labcorp", "url": "https://www.tradingview.com/news/zacks:fde895aa3094b:0-ilmn-stock-gains-following-expanded-collaboration-with-labcorp/", "date": "2026-03-19", "summary": "Illumina (ILMN) and Labcorp (LH) have expanded their collaboration to advance precision oncology using next-generation sequencing (NGS) solutions, leading to a 1.8% gain in Illumina's shares. This partnership aims to improve access to cancer biomarker testing, develop new IVD tests, and boost the adoption of comprehensive genomic profiling (CGP). The oncology market is projected to reach $866.1 billion by 2034, driven by rising cancer incidence and technological advancements, supporting positive", "sentiment_score": 0.305656, "sentiment_label": "Somewhat-Bullish", "relevance_score": 0.906602, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Drug Screening Market size to reach $40.18 Billion by 2035 | Key", "url": "https://www.openpr.com/news/4431300/drug-screening-market-size-to-reach-40-18-billion-by-2035-key", "date": "2026-03-19", "summary": "The global Drug Screening Market is projected to reach $40.18 billion by 2035, growing at a CAGR of 15.2% from 2026. This growth is driven by increasing substance abuse cases, stricter regulatory mandates for workplace drug testing, and technological advancements in screening methods. North America is expected to hold the largest market share, while Asia Pacific is anticipated to register significant growth.", "sentiment_score": 0.704733, "sentiment_label": "Bullish", "relevance_score": 0.999749, "sentiment": { "label": "neutral", "score": 0.026, "confidence": 0.03 } }, { "source": "alpha_vantage", "title": "A Look At Labcorp Holdings (LH) Valuation After Expanded Illumina Precision Oncology Alliance", "url": "https://www.sahmcapital.com/news/content/a-look-at-labcorp-holdings-lh-valuation-after-expanded-illumina-precision-oncology-alliance-2026-03-20", "date": "2026-03-19", "summary": "Labcorp Holdings (LH) has expanded its partnership with Illumina for precision oncology tests, making its stock a current focus. Despite a 1-year total shareholder return of 13.21% and being flagged as undervalued by about 32%, the article discusses whether current market pricing reflects future growth. It highlights anticipated revenue and earnings growth from new tests and AI-driven efficiency, while also noting potential pressures from tariffs, regulatory changes, and competition.", "sentiment_score": 0.040067, "sentiment_label": "Neutral", "relevance_score": 0.310101, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Labcorp expands PathAI partnership to deploy digital pathology platform nationwide", "url": "https://www.msn.com/en-us/health/other/labcorp-expands-pathai-partnership-to-deploy-digital-pathology-platform-nationwide/ar-AA1WTuBT", "date": "2026-03-18", "summary": "Labcorp is expanding its partnership with PathAI to implement a digital pathology platform across its U.S. network. This collaboration aims to enhance diagnostic capabilities and improve patient care through AI-powered insights. The platform will support more efficient and precise pathology services nationwide.", "sentiment_score": 0.432438, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.303, "confidence": 0.3 } }, { "source": "alpha_vantage", "title": "Labcorp outlines 5.4% midpoint revenue growth and 9% EPS target for 2026 while advancing specialty and AI initiatives", "url": "https://www.msn.com/en-us/money/companies/labcorp-outlines-54-midpoint-revenue-growth-and-9-eps-target-for-2026-while-advancing-specialty-and-ai-initiatives/ar-AA1WxI1k", "date": "2026-03-18", "summary": "Labcorp (LH) is targeting a 5.4% midpoint revenue growth and 9% EPS growth by 2026. The company plans to achieve this through strategic initiatives focusing on specialty testing, advancements in artificial intelligence, and enhancing its global presence. These goals were presented as part of the company's long-term financial outlook, signaling a strong growth trajectory.", "sentiment_score": 0.440496, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.582, "confidence": 0.58 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. stock underperforms Wednesday when compared to competitors", "url": "https://www.marketwatch.com/data-news/labcorp-holdings-inc-stock-underperforms-wednesday-when-compared-to-competitors-0969c0c7-8f146db0d2fd?gaa_at=eafs&gaa_n=AWEtsqcx8LOs-uZbuYYSfvWF8fNrjC3HL8aqR-CjLud16_0sbn634r-kAYFt&gaa_ts=69bf91c2&gaa_sig=yvs5h6coa0LgIQRovopGyqAH-NWzHZtP5id7jznwO0ESuyLZ39ZtoLsFM9ck2PruIEpuuSj3DhYY2m6Woq6Fgw%3D%3D", "date": "2026-03-18", "summary": "Labcorp Holdings Inc. (LH) stock fell 1.77% on Wednesday, closing at $265.84, underperforming the broader market as both the S&P 500 and Dow Jones Industrial Average experienced declines. This drop broke a three-day winning streak for the company's shares. The market experienced an overall grim trading session.", "sentiment_score": -0.296418, "sentiment_label": "Somewhat-Bearish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Illumina and Labcorp expand collaboration to broaden access to precision oncology testing", "url": "https://www.sahmcapital.com/news/content/illumina-and-labcorp-expand-collaboration-to-broaden-access-to-precision-oncology-testing-2026-03-18", "date": "2026-03-18", "summary": "Illumina and Labcorp have announced an expanded collaboration to advance precision oncology, focusing on broadening access to cancer biomarker testing and developing new diagnostic solutions. The partnership aims to bring advanced testing closer to patients through distributed test offerings, facilitate payer coverage, and address unmet needs in precision oncology. They will explore co-commercializing Labcorpโ€™s PGDx elioยฎ plasma focusโ„ข Dx liquid biopsy assay with Illuminaโ€™s TruSightโ„ข Oncology Co", "sentiment_score": 0.443776, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "Labcorpโ€“Illumina cancer pact targets wider access to genomic tests", "url": "https://www.stocktitan.net/news/LH/illumina-and-labcorp-expand-collaboration-to-broaden-access-to-7frcav5a76ne.html", "date": "2026-03-18", "summary": "Labcorp and Illumina have expanded their collaboration to enhance access to precision oncology testing. The initiative involves developing new IVD kits and comprehensive genomic profiling tests, generating clinical evidence for payer coverage, and exploring co-commercialization of FDA-authorized and approved assays. A joint study on over 7,600 NSCLC samples demonstrated the utility of genomic profiling in detecting actionable variants, reinforcing the clinical relevance of their efforts.", "sentiment_score": 0.40569, "sentiment_label": "Bullish", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.66, "confidence": 0.66 } }, { "source": "alpha_vantage", "title": "Illumina and Labcorp expand collaboration to broaden access to precision oncology testing", "url": "https://www.prnewswire.com/news-releases/illumina-and-labcorp-expand-collaboration-to-broaden-access-to-precision-oncology-testing-302716715.html", "date": "2026-03-18", "summary": "Illumina and Labcorp have expanded their collaboration to enhance precision oncology testing through innovative next-generation sequencing (NGS) solutions. The partnership aims to improve access to cancer biomarker testing, develop new diagnostic tests for unmet needs, and generate evidence for payer coverage. They also plan to co-commercialize Labcorp's liquid biopsy assay and Illumina's comprehensive solid tumor profiling product to broaden access for hospitals and community health systems.", "sentiment_score": 0.403968, "sentiment_label": "Bullish", "relevance_score": 0.935353, "sentiment": { "label": "positive", "score": 0.318, "confidence": 0.32 } }, { "source": "alpha_vantage", "title": "NeoGenomics, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Challenges", "url": "https://www.marketsmojo.com/news/stocks-in-action/neogenomics-inc-technical-trend-shifts-from-mildly-bearish-to-sideways-amid-stock-price-increase-3897100", "date": "2026-03-17", "summary": "NeoGenomics, Inc. (a small-cap pharmaceutical and biotechnology company) has revised its evaluation due to market fluctuations and performance challenges. The stock has shown recent price increases but significant volatility over the past year, underperforming the S&P 500 with a year-to-date return of -29.93% and a three-year decline of 57.63%. Technical indicators present mixed signals, with a bearish MACD weekly but mildly bullish monthly, and varying insights from RSI, Bollinger Bands, moving", "sentiment_score": -0.147294, "sentiment_label": "Neutral", "relevance_score": 0.599344, "sentiment": { "label": "positive", "score": 0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "VolitionRx Ltd Stock (ISIN: US92852X1037) Faces Prolonged Uncertainty Amid Diagnostics Stagnation", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/volitionrx-ltd-stock-isin-us92852x1037-faces-prolonged-uncertainty-amid/68701216", "date": "2026-03-17", "summary": "VolitionRx Ltd (VNRX), a developer of Nu.Q nucleosome-based diagnostic assays, is experiencing prolonged uncertainty with limited new developments as of mid-March 2026. The company faces challenges in commercializing its liquid biopsy platform for cancer, sepsis, and VTE detection, despite the growing global liquid biopsy market. Investors are advised to monitor for trial data, regulatory approvals, and strategic partnerships as potential catalysts for the high-risk, early-stage biotech stock.", "sentiment_score": 0.048317, "sentiment_label": "Neutral", "relevance_score": 0.646826, "sentiment": { "label": "negative", "score": -0.34, "confidence": 0.34 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. $LH Shares Bought by Gotham Asset Management LLC", "url": "https://www.marketbeat.com/instant-alerts/filing-labcorp-holdings-inc-lh-shares-bought-by-gotham-asset-management-llc-2026-03-17/", "date": "2026-03-17", "summary": "Gotham Asset Management LLC increased its stake in Labcorp Holdings Inc. by 39.2% in the third quarter, now owning 95,029 shares valued at $27,279,000. Other institutional investors also adjusted their positions, and corporate insiders sold over 16,000 shares worth approximately $4.5 million in the last three months. Labcorp recently announced a quarterly dividend of $0.72 per share and has received an average rating of \"Moderate Buy\" from analysts.", "sentiment_score": 0.213503, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "alpha_vantage", "title": "Banco Bilbao Vizcaya Argentaria S.A. Lowers Stock Holdings in Labcorp Holdings Inc. $LH", "url": "https://www.marketbeat.com/instant-alerts/filing-banco-bilbao-vizcaya-argentaria-sa-lowers-stock-holdings-in-labcorp-holdings-inc-lh-2026-03-17/", "date": "2026-03-17", "summary": "Banco Bilbao Vizcaya Argentaria S.A. reduced its stake in Labcorp Holdings Inc. by 55.3% in the third quarter, selling 18,987 shares and retaining 15,329 shares. Labcorp reported a beat on quarterly EPS ($4.07 vs. $3.95) and issued FY2026 guidance, while maintaining a \"Moderate Buy\" analyst rating. The company pays a quarterly dividend of $0.72 and has seen recent insider selling.", "sentiment_score": 0.116111, "sentiment_label": "Neutral", "relevance_score": 0.957488, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "California Public Employees Retirement System Lowers Holdings in Labcorp Holdings Inc. $LH", "url": "https://www.marketbeat.com/instant-alerts/filing-california-public-employees-retirement-system-lowers-holdings-in-labcorp-holdings-inc-lh-2026-03-17/", "date": "2026-03-17", "summary": "The California Public Employees Retirement System (CalPERS) reduced its stake in Labcorp Holdings Inc. by 13.5% in the third quarter of 2025, selling 38,811 shares. Despite CalPERS' reduction, other large institutions like Norges Bank, Lazard Asset Management, Victory Capital Management, Pacer Advisors Inc., and Wellington Management Group significantly increased their holdings, bringing institutional ownership to 95.94%. Labcorp reported strong Q4 2025 earnings per share, exceeding consensus es", "sentiment_score": 0.102182, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "negative", "score": -0.128, "confidence": 0.13 } }, { "source": "alpha_vantage", "title": "LH SEC Filings - Labcorp Holdings Inc 10-K, 10-Q, 8-K Forms", "url": "https://www.stocktitan.net/sec-filings/LH/page-5.html", "date": "2026-03-17", "summary": "This page provides a comprehensive resource for Labcorp Holdings (LH) SEC filings, including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms. It offers detailed information on the company's operations, financial condition, and governance, with AI-powered summaries to help users quickly grasp key points. Recent filings highlight executive and director equity awards, detailing grants of stock options and Restricted Stock Units (RSUs).", "sentiment_score": 0.133675, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Kewaunee Scientific stock (ISIN: US4925721028) faces margin pressure as lab-furniture demand softens", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/kewaunee-scientific-stock-isin-us4925721028-faces-margin-pressure-as/68696037", "date": "2026-03-16", "summary": "Kewaunee Scientific (NASDAQ: KEQU), a modular laboratory-furniture manufacturer, is experiencing softening demand and slowing order intake in early 2026, leading to margin pressure. While a stable backlog provides near-term revenue visibility, the lack of new orders raises concerns about demand durability and potential stock price reset risks if growth guidance is narrowed. The company faces challenges from elevated input and labor costs, and a recovery hinges on renewed customer confidence and ", "sentiment_score": -0.147366, "sentiment_label": "Neutral", "relevance_score": 0.602254, "sentiment": { "label": "negative", "score": -0.402, "confidence": 0.4 } }, { "source": "alpha_vantage", "title": "Myriad Genetics Inc Stock (ISIN: US62855J1043) Eyes Precision Medicine Growth Amid Margin Expansion", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/myriad-genetics-inc-stock-isin-us62855j1043-eyes-precision-medicine/68695366", "date": "2026-03-16", "summary": "Myriad Genetics Inc, a molecular diagnostics and precision-medicine platform, is at an inflection point, navigating robust demand for genetic testing against competitive pricing and reimbursement uncertainties. The company leverages a consumables-driven test model, installed-base expansion, and AI-enhanced interpretation tools to drive long-term growth, with European investors assessing its valuation amid industry consolidation. Key segments like oncology and reproductive health show promise, wi", "sentiment_score": 0.071701, "sentiment_label": "Neutral", "relevance_score": 0.60143, "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "alpha_vantage", "title": "Earnest Partners LLC Sells 7,799 Shares of Labcorp Holdings Inc. $LH", "url": "https://www.marketbeat.com/instant-alerts/filing-earnest-partners-llc-sells-7799-shares-of-labcorp-holdings-inc-lh-2026-03-15/", "date": "2026-03-15", "summary": "Earnest Partners LLC reduced its stake in Labcorp Holdings Inc. by 2.4% in the third quarter, selling 7,799 shares and holding a remaining 323,685 shares valued at approximately $92.9 million. This sale follows significant insider selling totaling 16,113 shares last quarter, including CEO Adam Schechter, reducing insider ownership to 0.84%. Despite this, analysts maintain a \"Moderate Buy\" consensus with a target price of $304.82, and Labcorp recently exceeded EPS estimates while providing strong", "sentiment_score": 0.10034, "sentiment_label": "Neutral", "relevance_score": 1.0, "sentiment": { "label": "positive", "score": 0.67, "confidence": 0.67 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. $LH Stock Position Lifted by 8 Knots Management LLC", "url": "https://www.marketbeat.com/instant-alerts/filing-labcorp-holdings-inc-lh-stock-position-lifted-by-8-knots-management-llc-2026-03-15/", "date": "2026-03-15", "summary": "8 Knots Management LLC significantly increased its stake in Labcorp Holdings Inc. (NYSE:LH) by 96.6% during the third quarter, making it their fourth-largest holding. Other institutional investors also adjusted their positions in Labcorp, which currently has a \"Moderate Buy\" consensus rating from analysts with an average target price of $304.82. Labcorp recently announced a quarterly dividend of $0.72 per share and reported strong Q4 earnings, beating analyst estimates.", "sentiment_score": 0.2645, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Labcorp Holdings Inc. (NYSE:LH) Given Average Recommendation of \"Moderate Buy\" by Brokerages", "url": "https://www.marketbeat.com/instant-alerts/labcorp-holdings-inc-nyselh-given-average-recommendation-of-moderate-buy-by-brokerages-2026-03-15/", "date": "2026-03-15", "summary": "Labcorp Holdings Inc. (NYSE:LH) has received an average \"Moderate Buy\" rating from brokerages, based on reports from twelve ratings firms. The company's shares opened at $263.57, with a market capitalization of $21.72 billion. Several analysts have recently updated their price targets and ratings, and the company recently announced a quarterly dividend of $0.72 per share, representing an annualized dividend of $2.88.", "sentiment_score": 0.347085, "sentiment_label": "Somewhat-Bullish", "relevance_score": 1.0, "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "alpha_vantage", "title": "Charles River Laboratories Stock (ISIN: US1591881009) Surges on Earnings Beat and $1B Buyback Amid R", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/charles-river-laboratories-stock-isin-us1591881009-surges-on-earnings/68682127", "date": "2026-03-15", "summary": "Charles River Laboratories (NYSE:CRL) stock surged after reporting stronger-than-expected quarterly results, announcing a $1 billion share repurchase program, and initiating strategic restructuring. The company, a leading provider of drug discovery and development services, saw its stock rise 1.83% on March 13, 2026, contributing to a 23.20% year-to-date advance. Investors are balancing operational improvements and restructuring efforts against ongoing challenges in the life sciences sector.", "sentiment_score": 0.107309, "sentiment_label": "Neutral", "relevance_score": 0.620882, "sentiment": { "label": "positive", "score": 0.2, "confidence": 0.2 } }, { "source": "alpha_vantage", "title": "Integral Health Asset Management LLC Sells 65,000 Shares of Quest Diagnostics Incorporated $DGX", "url": "https://www.marketbeat.com/instant-alerts/filing-integral-health-asset-management-llc-sells-65000-shares-of-quest-diagnostics-incorporated-dgx-2026-03-14/", "date": "2026-03-14", "summary": "Integral Health Asset Management LLC reduced its stake in Quest Diagnostics (NYSE:DGX) by 43.3%, selling 65,000 shares and now owning 85,000 shares valued at approximately $16.20 million. This move comes as Quest Diagnostics exceeded quarterly earnings and revenue estimates, provided strong FY2026 guidance, and announced a $1.0 billion share buyback program alongside an increased quarterly dividend. Analysts currently rate the stock as a \"Moderate Buy\" with an average target price of $210.29.", "sentiment_score": 0.142893, "sentiment_label": "Neutral", "relevance_score": 0.628263, "sentiment": { "label": "positive", "score": 0.572, "confidence": 0.57 } }, { "source": "alpha_vantage", "title": "Guardant Health (GH) Valuation Check As Shield Across America Expands Colorectal Cancer Screening Reach", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-gh/guardant-health/news/guardant-health-gh-valuation-check-as-shield-across-america", "date": "2026-03-14", "summary": "Guardant Health (GH) recently launched \"Shield Across America,\" a mobile screening tour for its colorectal cancer blood test, Shield, amidst a 20.53% decline in its 30-day share price but a strong 99.32% 1-year return. Despite short-term price drops, the company's valuation narrative suggests it's 35.5% undervalued at $132.57 per share compared to its current $85.49, driven by significant regulatory and clinical milestones for Shield that promise future revenue growth. However, investors are cau", "sentiment_score": 0.124341, "sentiment_label": "Neutral", "relevance_score": 0.616369, "sentiment": { "label": "negative", "score": -0.599, "confidence": 0.6 } }, { "source": "pubmed", "pmid": "41894644", "title": "Baseline Urinary Calcium and the Efficacy of Thiazide Diuretics for Kidney Stone Prevention.", "authors": "Hsi RS et al.", "journal": "The Journal of urology", "date": "2026 Mar 2", "url": "https://pubmed.ncbi.nlm.nih.gov/41894644/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "edgar_news", "title": "Labcorp Holdings Inc.", "text": "Labcorp Holdings Inc. and Laboratory Corporation of America Holdings entered a $750M senior unsecured term loan agreement with Wells Fargo, maturing March 20, 2028, with SOFR-based or base rate interest. The agreement includes covenants and a leverage ratio not exceeding 4.0 to 1.0.\n\n*Labcorp Holdings Inc. [LH](https://www.google.com/finance/quote/LH:NYSE) is headquartered in Burlington, NC.*\n\n[Source](https://www.sec.gov/Archives/edgar/data/920148/000119312526117879/d38637d8k.htm)", "author": "edgar_news_01", "score": 1, "num_comments": 0, "date": "2026-03-20", "url": "https://reddit.com/r/edgar_news/comments/1rz90kx/labcorp_holdings_inc/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "EverHint", "title": "EverHint โ€“ EMA10 ร— EMA30 Crossover โ€“ Top 10 Buy and Top 10 Sell Signals for Mar 11, 2026", "text": "## What This Signal Is (Quick)\n\nThis strategy detects **fresh crossovers** between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30):\n\n * **Buy Signal (EMA10_x_EMA30_Buy)** : EMA(10) crosses **above** EMA(30) on today's close\n\n * Short-term momentum overtakes medium-term trend\n * Suggests acceleration in upward price movement\n * Ideal for swing trading (1-4 week holding periods)\n * **Sell Signal (EMA10_x_EMA30_Sell)** : EMA(10) crosses **b", "author": "Mamuthone125", "score": 1, "num_comments": 0, "date": "2026-03-12", "url": "https://reddit.com/r/EverHint/comments/1rreauq/everhint_ema10_ema30_crossover_top_10_buy_and_top/", "sentiment": { "label": "positive", "score": 0.382, "confidence": 0.38 } }, { "source": "reddit", "subreddit": "InterstellarKinetics", "title": "BREAKING: Google Just Reached True Quantum Supremacy By Processing Data 13,000 Times Faster Than The World's Best Supercomputer ๐Ÿค–๐Ÿ”ฅ", "text": "Google has officially pushed quantum computing out of the theoretical laboratory and into reality this weekend, announcing a staggering breakthrough with its new \"Quantum Echoes\" algorithm. Running on the company's highly advanced Willow chip, the system successfully completed a highly complex molecular modeling task roughly 13,000 times faster than the most powerful classical supercomputer on Earth. What makes this specific milestone so groundbreaking is that the results were entirely verifiabl", "author": "InterstellarKinetics", "score": 1189, "num_comments": 137, "date": "2026-03-15", "url": "https://reddit.com/r/InterstellarKinetics/comments/1ruq56j/breaking_google_just_reached_true_quantum/", "sentiment": { "label": "positive", "score": 0.735, "confidence": 0.74 } }, { "source": "reddit", "subreddit": "Costco", "title": "Costco Announces Partnership with Sesame and IVI RMA (World's Largest Assisted Reproduction Group) to Expand Fertility Care, Cut Medication Costs by 80% for Costco Members", "text": "[Sesame, IVI RMA, and Costco Transform Fertility Care for Costco Members with New Partnership Offering Expanded Access to Quality Care and 80% Medication Savings](https://www.businesswire.com/news/home/20260309898627/en/Sesame-IVI-RMA-and-Costco-Transform-Fertility-Care-for-Costco-Members-with-New-Partnership-Offering-Expanded-Access-to-Quality-Care-and-80-Medication-Savings)\n\nThree industry leaders,ย Costco,ย Sesame, andย IVI RMA North America, recently announced a strategic partnership to transf", "author": "AutoModerator", "score": 1989, "num_comments": 52, "date": "2026-03-14", "url": "https://reddit.com/r/Costco/comments/1rt7jqs/costco_announces_partnership_with_sesame_and_ivi/", "sentiment": { "label": "positive", "score": 0.727, "confidence": 0.73 } }, { "source": "reddit", "subreddit": "jobs", "title": "Confirmed Upcoming Layoffs: February 2026", "text": "Amazon\n\nTyson Foods\n\nDel Monte Foods\n\nMeta Platforms\n\nHRL Laboratories\n\nPhillips 66\n\nFrito-Lay\n\nBristol Myers Squibb\n\nBlue Cross Blue Shield\n\nAlameda Health System\n\nValero Refining\n\nNaples Grande Beach Resort\n\nL.A. Care Health Plan\n\nConstellation Brands\n\nUKG\n\nDHL Supply Chain\n\nThermo Fisher Scientific\n\nWorkday\n\nJPMorgan Chase\n\nPinterest\n\nAmerican Eagle Outfitters\n\nBest Buy\n\nAutodesk\n\nMacyโ€™s\n\nMedtronic\n\nLegacy Supply Chain\n\nRSVC Company\n\nIntrepid Studios\n\nInnovation Bakers\n\nLiberty Dental Plan\n\nH", "author": "jgold_10", "score": 679, "num_comments": 164, "date": "2026-02-26", "url": "https://reddit.com/r/jobs/comments/1reziw2/confirmed_upcoming_layoffs_february_2026/", "sentiment": { "label": "negative", "score": -0.2, "confidence": 0.2 } }, { "source": "reddit", "subreddit": "vintageaudio", "title": "Vintage system in brand new condition", "text": "Parents purchased this in 1989 I believe. They have all original paperwork and everything is still in tact. \n\nThey paid $2400 all in back then.\n\nDo these still hold any value? Itโ€™s not wired up to use but debating to keep or sell. \n\nItโ€™s the SC-S400 model\n\nI kind of really want to set it up again to use the turntable, been awhile since I listened to music that way. They have a bunch of old records Iโ€™ve yet to go through ", "author": "Sparks_travel", "score": 454, "num_comments": 133, "date": "2026-02-27", "url": "https://reddit.com/r/vintageaudio/comments/1rgd6f6/vintage_system_in_brand_new_condition/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "VideojuegosMX", "title": "Soy una chica feliz, me voy a asustar pero sere feliz", "text": "", "author": "h0rnylibrarian", "score": 527, "num_comments": 83, "date": "2026-03-03", "url": "https://reddit.com/r/VideojuegosMX/comments/1rjajz9/soy_una_chica_feliz_me_voy_a_asustar_pero_sere/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "VHS", "title": "When I think of collecting tapes this one first comes to mind. Essential for any collection. IMO Name another one.", "text": "", "author": "simplejoe1992", "score": 162, "num_comments": 157, "date": "2026-03-05", "url": "https://reddit.com/r/VHS/comments/1rlnzx0/when_i_think_of_collecting_tapes_this_one_first/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "limbuscompany", "title": "I just noticed something about K Corp....", "text": "So K Corp's staff and presumably most people in the district work 70 hours a week. The only way this could be feasibly spread evenly across a week is either if employees take two days off and work 14 hours for five days a week, or if they take no days off and work 10 hours a day. Considering that most forms of vacation are borderline mythical in The City, I find it unlikely that anyone outside of the elite get a weekly day off much less two. So I think its more probable that K Corp's employees w", "author": "DornsUnusualRants", "score": 533, "num_comments": 47, "date": "2026-03-05", "url": "https://reddit.com/r/limbuscompany/comments/1rl3czy/i_just_noticed_something_about_k_corp/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "dutchbunnymafia", "title": "I was recommended this sub for my boy Oreo ๐Ÿ’–๐Ÿฐ", "text": "I've been told he has large ears for a Dutchie ๐Ÿ‘‚๐Ÿฐ I don't really have much reference lol", "author": "SparklyRatTheFirst1", "score": 478, "num_comments": 34, "date": "2026-03-19", "url": "https://reddit.com/r/dutchbunnymafia/comments/1ry36u9/i_was_recommended_this_sub_for_my_boy_oreo/", "sentiment": { "label": "positive", "score": 0.802, "confidence": 0.8 } }, { "source": "reddit", "subreddit": "ArtificialSentience", "title": "Is Claude conscious?", "text": "Anthropic was founded to study the potentialโ€”and the risksโ€”of A.I. Since state-of-the-art experiments required access to a state-of-the-art model, the company developed its own prototype as a private โ€œlaboratory.โ€ And thus was born Claude, its chatbot, mascot, collaborator, friend, and experimental patient.\n\nAnthropic staff run a range of experiments with Claude to determine what it is โ€œlikeโ€โ€”giving it control of a company fridge; instructing it to talk constantly about bananas but to never reve", "author": "KittenBotAi", "score": 38, "num_comments": 93, "date": "2026-03-26", "url": "https://reddit.com/r/ArtificialSentience/comments/1s3zm28/is_claude_conscious/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "xbox", "title": "Halo 2 Collectors Edition", "text": "just wanted to share my copy of Halo 2 complete with the inserts and slip cover. I went to the midnight launch at the mall with my dad and waited in line. got to play for a few hours before school. everyone at school was asking me all about it that day. I was 14 at the time", "author": "gammage01", "score": 283, "num_comments": 46, "date": "2026-03-01", "url": "https://reddit.com/r/xbox/comments/1ri2g87/halo_2_collectors_edition/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "distractible", "title": "Good AI: The Scary Tapes FAQ", "text": "Since there's been a bit of confusion, I wanted to post here to clarify what Real Good AI is and how \" the scary tapes \" contest from the most recent episode works. \n\nYes, this is copied and pasted from the website. I felt it best not to take words out of some amazing people's mouths, so having them explain it is better than me making alphabet soup and watering down their answers. \n\nAll of this info can be found on the Real Good AI website, found here: \n\n[https://www.realgoodai.org/newsletter/s", "author": "Monica2796", "score": 328, "num_comments": 25, "date": "2026-03-24", "url": "https://reddit.com/r/distractible/comments/1s2i186/good_ai_the_scary_tapes_faq/", "sentiment": { "label": "negative", "score": -0.077, "confidence": 0.08 } }, { "source": "reddit", "subreddit": "u_ResidentEvilGames", "title": "Raccoon City Lockdown Extended to 2040", "text": "https://preview.redd.it/4q10ldwegnlg1.png?width=1280&format=png&auto=webp&s=fc4e3512b26f223aa022d719e19ab13db9e11613\n\nIn 1998, a catastrophic incident shook Raccoon City when a virus, developed by the pharmaceutical giant Umbrella, leaked from a laboratory and spread rapidly throughout the area. Despite the valiant efforts of the local police force, they were unable to contain the crisis, and the infection quickly spiraled out of control, plunging the city into chaos and despair.\n\nhttps://previe", "author": "ResidentEvilGames", "score": 349, "num_comments": 28, "date": "2026-02-27", "url": "https://reddit.com/r/u_ResidentEvilGames/comments/1rfxjat/raccoon_city_lockdown_extended_to_2040/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "eductionalpartner", "title": "learning management systems LMS Online assignments Help via Moodle, Canvas, Blackboard, Brightspace, Pearson MyLab, McGraw-Hill, Cengage, Google Classroom To do my Written essays, reports, Timed quizzes, tests, Discussion board posts, Group projects, presentations, Case studies & reflections Reddit!", "text": "https://reddit.com/link/1rvzoi8/video/kwbeewdtxvbg1/player\n\n**If you're Struggling with your online exams, class, assignment/homework or any other task, Contact Us for Help:**\n\n**Website: hiraedu. com**\n\n**WhatsApp: +12136359834**\n\n**WhatsApp: +16124914941**\n\n**Call: +12136359834**\n\n**Call: +17273080530**\n\n๐ˆ ๐‡๐„๐‹๐ ๐–๐ˆ๐“๐‡ ๐€๐‹๐‹ ๐„๐—๐€๐Œ๐’: Whether you take an Exam at school or at home (even if it's proctored), I can take it for you and get you a high grade! 100% success rates!\n\n๐Œ๐˜ ๐“๐„๐€๐Œ ๐€๐๐ƒ ๐ˆ ๐‚๐€๐ ๐‡๐€๐๐ƒ๐‹๐„ ๐“๐‡๐„", "author": "ccna_cisco", "score": 3, "num_comments": 81, "date": "2026-03-17", "url": "https://reddit.com/r/eductionalpartner/comments/1rvzoi8/learning_management_systems_lms_online/", "sentiment": { "label": "positive", "score": 0.457, "confidence": 0.46 } }, { "source": "reddit", "subreddit": "mathshelper", "title": "Canvas Exam Help Online | Pay someone to take my Canvas exam | Pay Someone to do my Canvas Class | Do my Canvas Homework | Do my Canvas Assignment | Take my Canvas QUIZ | Canvas Test Taker Hire | College Math Chemistry Statistics Accounting Calculus Business Physics Tutoring Exam Help Hiraedu Reddit", "text": "**If you're Struggling with your online exams, class, assignment/homework or any other task, Contact Us for Help:**\n\n**Website: hiraedu. com**\n\n**WhatsApp: +12136359834**\n\n**WhatsApp: +16124914941**\n\n**Call: +12136359834**\n\n**Call: +17273080530**\n\n๐ˆ ๐‡๐„๐‹๐ ๐–๐ˆ๐“๐‡ ๐€๐‹๐‹ ๐„๐—๐€๐Œ๐’: Whether you take an Exam at school or at home (even if it's proctored), I can take it for you and get you a high grade! 100% success rates!\n\n๐Œ๐˜ ๐“๐„๐€๐Œ ๐€๐๐ƒ ๐ˆ ๐‚๐€๐ ๐‡๐€๐๐ƒ๐‹๐„ ๐“๐‡๐„ ๐…๐Ž๐‹๐‹๐Ž๐–๐ˆ๐๐† ๐€๐‚๐€๐ƒ๐„๐Œ๐ˆ๐‚ ๐“๐€๐’๐Š๐’ ๐…๐Ž๐‘ ๐˜๐Ž๐”:\n\nProctored Exams | Quizze", "author": "Live_Caramel8101", "score": 1, "num_comments": 81, "date": "2026-03-01", "url": "https://reddit.com/r/mathshelper/comments/1rhznz3/canvas_exam_help_online_pay_someone_to_take_my/", "sentiment": { "label": "positive", "score": 0.557, "confidence": 0.56 } }, { "source": "reddit", "subreddit": "Bunnies", "title": "Trying to teach Oreo about comics", "text": "", "author": "SparklyRatTheFirst1", "score": 314, "num_comments": 23, "date": "2026-03-14", "url": "https://reddit.com/r/Bunnies/comments/1rtlpe2/trying_to_teach_oreo_about_comics/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "eductionalpartner", "title": "learning management systems LMS Online assignments Help via Moodle, Canvas, Blackboard, Brightspace, Pearson MyLab, McGraw-Hill, Cengage, Google Classroom To do my Written essays, reports, Timed quizzes, tests, Discussion board posts, Group projects, presentations, Case studies & reflections Reddit!", "text": "https://reddit.com/link/1rjjr5y/video/kwbeewdtxvbg1/player\n\n**If you're Struggling with your online exams, class, assignment/homework or any other task, Contact Us for Help:**\n\n**Website: hiraedu. com**\n\n**WhatsApp: +12136359834**\n\n**WhatsApp: +16124914941**\n\n**Call: +12136359834**\n\n**Call: +17273080530**\n\n๐ˆ ๐‡๐„๐‹๐ ๐–๐ˆ๐“๐‡ ๐€๐‹๐‹ ๐„๐—๐€๐Œ๐’: Whether you take an Exam at school or at home (even if it's proctored), I can take it for you and get you a high grade! 100% success rates!\n\n๐Œ๐˜ ๐“๐„๐€๐Œ ๐€๐๐ƒ ๐ˆ ๐‚๐€๐ ๐‡๐€๐๐ƒ๐‹๐„ ๐“๐‡๐„", "author": "ccna_cisco", "score": 3, "num_comments": 76, "date": "2026-03-03", "url": "https://reddit.com/r/eductionalpartner/comments/1rjjr5y/learning_management_systems_lms_online/", "sentiment": { "label": "positive", "score": 0.457, "confidence": 0.46 } }, { "source": "reddit", "subreddit": "vintageaudio", "title": "Found in an old playboy", "text": "Thought yall might like this", "author": "alphrask", "score": 149, "num_comments": 41, "date": "2026-03-13", "url": "https://reddit.com/r/vintageaudio/comments/1rsqri7/found_in_an_old_playboy/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "X360Collectors", "title": "New pickup!", "text": "Quite uncommon to find with the slipcover, anyone else have this?", "author": "DigitalVigilante", "score": 354, "num_comments": 17, "date": "2026-03-01", "url": "https://reddit.com/r/X360Collectors/comments/1rhnu96/new_pickup/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "DisagreeMythoughts", "title": "DMT: My allergy medication costs 600 dollars because of a legal trick, not innovation", "text": "I carry an EpiPen because my body mistakes peanuts for poison. The device contains epinephrine, a hormone first synthesized in 1901. The auto-injector mechanism was patented in 1977. Both have been generic for decades. Yet in 2024, a two-pack costs between three and six hundred dollars, depending on my insurance and my pharmacy's mood.\n\nThe same device, with the same drug, sells for one hundred dollars in Canada and thirty in the United Kingdom. The difference is not shipping cost or regulatory ", "author": "TheBigGirlDiaryBack", "score": 77, "num_comments": 48, "date": "2026-03-06", "url": "https://reddit.com/r/DisagreeMythoughts/comments/1rmgpb3/dmt_my_allergy_medication_costs_600_dollars/", "sentiment": { "label": "neutral", "score": -0.022, "confidence": 0.02 } }, { "source": "reddit", "subreddit": "Westerns", "title": "Pat Garrett & Billy the Kid", "text": "I just picked up the Criterion of Pat Garrett & Billy the Kid. This features the 50th anniversary release and the theatrical release on 4K, as well as Sam Peckinpah's final preview cut on bluray. I've never seen the movie but I'm starting with the 50th anniversary release. I've read about the development hell this went through and it seems like the theatrical version is the worst version.", "author": "No_Move7872", "score": 84, "num_comments": 39, "date": "2026-03-12", "url": "https://reddit.com/r/Westerns/comments/1rrc18z/pat_garrett_billy_the_kid/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "agi", "title": "Is Claude conscious?", "text": "Anthropic was founded to study the potentialโ€”and the risksโ€”of A.I. Since state-of-the-art experiments required access to a state-of-the-art model, the company developed its own prototype as a private โ€œlaboratory.โ€ And thus was born Claude, its chatbot, mascot, collaborator, friend, and experimental patient.\n\nAnthropic staff run a range of experiments with Claude to determine what it is โ€œlikeโ€โ€”giving it control of a company fridge; instructing it to talk constantly about bananas but to never reve", "author": "KittenBotAi", "score": 2, "num_comments": 50, "date": "2026-03-26", "url": "https://reddit.com/r/agi/comments/1s3znja/is_claude_conscious/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } }, { "source": "reddit", "subreddit": "HGRAF", "title": "HGRAF: I Dug Through the Interviews.", "text": "So I went through multiple interviews that I could find on YouTube to just go through and update all the information I currently have on hand. I would like to share what I have so far. Hopefully this is helpful for some of you. \n\n\nNow while I do believe this company's product is real, and the market potential is real, they still have to prove themselves in scaling and execution. And the 1 burning question I have that is never answered is this: What is the actual value proposition for different ", "author": "UnbrokenChill", "score": 58, "num_comments": 42, "date": "2026-03-08", "url": "https://reddit.com/r/HGRAF/comments/1rnpql0/hgraf_i_dug_through_the_interviews/", "sentiment": { "label": "neutral", "score": 0.0, "confidence": 0.0 } } ] } }